Overview

• Beth Harris initially received two courses of antibiotics for what her GP diagnosed as a chest infection, but her symptoms persisted.
• Scans revealed stage two B-cell lymphoma, a blood cancer involving abnormal white blood cell growth forming tumors in her chest and neck.
• Her treatment plan was modified to an intensive three-month chemotherapy schedule due to fluid around her heart, a complication of her condition.
• Following chemotherapy, Beth will transition to oral medication, with remission targeted by October 2025.
• Doctors noted that without timely intervention, her condition could have been fatal by the end of the year.